HM
CLVS

HealthCor Management’s Clovis Oncology, Inc. CLVS Stock Holding History

HealthCor Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,491,376
Closed -$5.86M – 70
2019
Q3 		$5.86M Sell
1,491,376
-156,714
-10% -$1.27M 0.22% 47
2019
Q2 		$24.5M Buy
1,648,090
+249,790
+18% +$4.51M 0.95% 36
2019
Q1 		$34.7M Buy
+1,398,300
New +$35.1M 1.4% 29
2018
Q1 		– Sell
-973,840
Closed -$66.2M – 56
2017
Q4 		$66.2M Buy
973,840
+326,420
+50% +$22.8M 2.16% 23
2017
Q3 		$53.3M Buy
647,420
+401,120
+163% +$31.8M 1.79% 21
2017
Q2 		$23.1M Sell
246,300
-53,700
-18% -$3.29M 0.83% 31
2017
Q1 		$19.1M Sell
300,000
-325,000
-52% -$19.8M 0.88% 27
2016
Q4 		$27.8M Sell
625,000
-75,000
-11% -$2.64M 1.57% 21
2016
Q3 		$25.2M Sell
700,000
-1,950,000
-74% -$41.8M 1.54% 23
2016
Q2 		$36.4M Buy
2,650,000
+650,000
+33% +$9.5M 1.98% 17
2016
Q1 		$38.4M Buy
2,000,000
+475,000
+31% +$10.1M 2.18% 17
2015
Q4 		$53.4M Buy
+1,525,000
New +$98.3M 3.24% 13
2014
Q2 		– Sell
-475,000
Closed -$32.9M – 70
2014
Q1 		$32.9M Buy
475,000
+376,437
+382% +$27.6M 1.98% 20
2013
Q4 		$5.94M Sell
98,563
-157,458
-62% -$8.56M 0.36% 41
2013
Q3 		$15.6M Buy
256,021
+131,021
+105% +$9.29M 0.83% 37
2013
Q2 		$8.37M Buy
+125,000
New +$5.62M 0.51% 39

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

HealthCor Management's CLVS Position: Q4 2019 in Review

HealthCor Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 1,491,376 shares — an estimated $5.86M sold.

HealthCor Management first reported a position in CLVS in Q2 2013 and held it in 16 quarters. The position peaked at $66.2M in Q4 2017. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

  • HealthCor Management reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
  • HealthCor Management sold 1,491,376 Clovis Oncology, Inc. shares in Q4 2019, an estimated $5.86M.
  • HealthCor Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 16 quarters.
  • HealthCor Management's Clovis Oncology, Inc. position peaked at $66.2M in Q4 2017.
  • 147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on HealthCor Management's 13F filing for Q4 2019, filed 14 Feb 2020.